NEUROSCIENCE 2022
"First presentation at SfN 2022 in San Diego as a PostDoc. So nice to share the results of my work to an audience after a 2 year long covid break. So many impressions and really friendly people in the neuroscience community." - Dr. Marko Jörg
30. JAHRESTAGUNG DER DGSM 2022
"It was a great pleasure and a nice experience to present the results of my PhD at the 30th Annual Meeting of the DGSM 2022. The conference offered many exciting lectures on sleep medicine and interesting insights into the industry." - Vanessa Efinger
NEW PAPER OUT
El Hamdaoui, Y., Zheng, F., Fritz, N., Ye, L., Tran, M. A., Schwickert, K., Schirmeister, T., Braeuning, A. Lichtenstein, D., Hellmich, U. A., Weikert, D., Heinrich, M., Treccani, G., Schäfer, M. K. E., Nowak, G., Nürnberg, B., Alzheimer, Ch., Müller, Ch. P., Friedland, K. Analysis of hyperforin (St. John’s wort) action at TRPC6 channel leads to the development of a new class of antidepressant drugs. (2022) Mol Psychiatry. https://doi.org/10.1038/s41380-022-01804-3